[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345861-105":59,"doc-detail-345861-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multifactorial-sheltering-in-peristromal-niches-shapes-in-vivo-responses-of-lung-cancers-to-targeted-therapies","Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies","","Targeted therapies can trigger strong, durable remissions, yet advanced cancers often persist and later evolve resistance as some tumor cells survive residual disease. While many cell-intrinsic and microenvironmental mechanisms have been proposed for persistence and resistance, their relative in vivo contributions remain unclear. Using spatial histological inferences in ALK+ NSCLC models, the study shows that peristromal niches shield tumor cells from elimination via multiple juxtacrine and paracrine signals, sustaining residual populations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multifactorial-sheltering-in-peristromal-niches-shapes-in-vivo-responses-of-lung-cancers-to-targeted-therapies/345861/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multifactorial-sheltering-in-peristromal-niches-shapes-in-vivo-responses-of-lung-cancers-to-targeted-therapies/345861.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do targeted therapies fail to eliminate advanced lung cancers completely?","Question",{"text":112,"@type":113},"A subset of tumor cells survives within residual disease and eventually develops resistance, even after strong clinical responses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does the tumor microenvironment play in therapy resistance?",{"text":117,"@type":113},"Paracrine and juxtacrine factors produced by tumor stroma can confer resistance to otherwise sensitive tumor cells, leading to stroma-mediated resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the study assess in vivo sheltering mechanisms in ALK+ NSCLC models?",{"text":121,"@type":113},"It uses spatial histological inferences from ALK+ NSCLC models to show that peristromal niches protect tumor cells from elimination and sustain residual populations.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345861,1790140168,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","| |  |  | |\n| --- | --- | --- | --- |\n| Article [https://doi.org/10.1038/s41467-026-73454-w](https://doi.org/10.1038/s41467-026-73454-w) |  |  |  |\n| Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies |  |  |  |\n| Received: 2 April 2025\u003Cbr>Accepted: 8 May 2026 Check for updates | Bina Desai 1,2, Tatiana Miti3, Sandhya Prabhakaran 3,\u003Cbr>Daria Miroshnychenko 1, Pragya Kumar 1, Menkara Henry1, Viktoriya Marusyk1, Natalia Souza Nunes Siqueira 1, Chandler Gatenbee 3, Hilal Ozakinci4, Marilyn Bui 5,6, Theresa A. Boyle 4,5, Jacob Scott 7, Philipp M. Altrock 8, Bruna Pellini4,10, Eric Haura4, Alexander R. A. Anderson 3, David Basanta3 & Andriy Marusyk 1,9 \u003Cbr>Targeted therapies induce strong clinical responses but fail to eliminate advanced cancers, as a subset of tumor cells survives within residual disease and eventually develops resistance. While numerous cell-intrinsic and microenvironmental mechanisms have been implicated in this survival, their relative contributions remain poorly deﬁned. Using spatial histological inferences from ALK + NSCLC models, we show that peristromal niches protect tumor cells from elimination, enabling in vivo persistence. This spatially restricted sheltering provides an ecological rescue mechanism that sustains residual populations, enabling their eventual evolutionary escape. Mechanistically, this protective effect reﬂects an integrated action of multiple juxtacrine and paracrine signals. This complexity limits the utility of targeting individual mechanisms of protection, favoring a shift towards exploiting orthogonal collateral sensitivities of residual disease. We ﬁnd that adaptive HER2 upregulation, associated with both cell-intrinsic and stroma-mediated persistence, can be exploited by the antibody-drug conjugate T-DXd to dramatically enhance therapeutic responses and suppress tumor relapse. |  |  |\n| Therapies that target oncogenic signaling addictions can induce strong and durable remissions in cancers deﬁned by relevant mutational drivers. However, a subset of tumor cells typically persists under therapy, eventually giving rise to resistance. The main effort in the quest to solve the challenge of the inevitable failure of targeted |  | therapies has been directed against the identiﬁcation and targeting of the molecular mechanisms that underlie cancer survival (persistence) and resistance (positive net growth). This effort has led to the uncovering of a large and growing number of molecular mechanisms, including mutational changes in therapeutic targets, mutational or |  |\n\n1Department of Tumor Microenvironment and Metastasis, H Lee Mofﬁtt Cancer Center and Research Institute, Tampa, FL, USA. 2Cancer Biology Ph. D. Program, University of South Florida, Tampa, FL, USA. 3Department of Integrated Mathematical Oncology, HLee Mofﬁtt Cancer Center and Research Institute, Tampa, FL, USA. 4Department of Thoracic Oncology, H. Lee Mofﬁtt Cancer Center and Research Institute, Tampa, FL, USA. 5Department of Machine Learning, H. Lee Mofﬁtt Cancer Center and Research Institute, Tampa, FL, USA. 6Department of Pathology, H. Lee Mofﬁtt Cancer Center and Research Institute, Tampa, FL, USA. 7Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA. 8Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany. 9Department of Molecular Medicine, University of South Florida, Tampa, FL, USA. 10Present address: Department of Thoracic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.  \ne-mail: andriy.marusyk@mofﬁ[tt.org](tt.org)  \nnon-mutational activation of bypass signaling, histological transformation, and others1. However, apart from the introduction of more potent inhibitors capable of overcoming some common on-target mutational resistance mechanisms, the translational impact of this knowledge has been limited.  \nOne of the challenges w","cbCaisCWQjOafIU8","https://ap.wps.com/l/cbCaisCWQjOafIU8","pdf",3616492,17,"English","# Received and accepted timeline\n# Mechanistic background and therapeutic challenge\n## Cell-intrinsic persistence and resistance\n## Stroma-mediated resistance and tumor microenvironment\n# In vivo inference strategy using ALK+ NSCLC models\n## Peristromal niche protection and ecological rescue\n## Integrated juxtacrine and paracrine signaling","[{\"question\":\"Why do targeted therapies fail to eliminate advanced lung cancers completely?\",\"answer\":\"A subset of tumor cells survives within residual disease and eventually develops resistance, even after strong clinical responses.\"},{\"question\":\"What role does the tumor microenvironment play in therapy resistance?\",\"answer\":\"Paracrine and juxtacrine factors produced by tumor stroma can confer resistance to otherwise sensitive tumor cells, leading to stroma-mediated resistance.\"},{\"question\":\"How does the study assess in vivo sheltering mechanisms in ALK+ NSCLC models?\",\"answer\":\"It uses spatial histological inferences from ALK+ NSCLC models to show that peristromal niches protect tumor cells from elimination and sustain residual populations.\"}]","Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies | PDF",1790059174,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2213020f344bdbb3ea0dd9938bd4f8d5.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb846a22b60db2353ac7bb8d1dc84e10.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad529457d44cc706eeaad967e191a94c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7db60c4907b50c5347b6c5856a8a548.webp",980,1301]